Lipogems® is a new and innovative treatment that has now helped over 30,000 patients worldwide.

We are the only clinic in the UK that has the expertise and exclusivity to deliver the Lipogems regenerative treatment for the urogenital area in women.

It has been extensively researched, please see some of the key clinical papers below. The treatment has simply life changing results in both
orthopaedic, gynaecological and rejuvenation applications.

Clinical Papers Lipogems

Menopause: new frontiers in the treatment of urogenital atrophy
 
Stem cell therapies in Obstetrics and Gynaecology
 

Mesenchymal stem cells
Potential for therapy and treatment of chronic non-healing skin wounds: Organogenesis: Vol 11, No 4

Tremolada Overview and Science 2016
Adipose Tissue and Mesenchymal Stem Cells: State of the Art and Lipogems® Technology Development
Rizzoli protocol EN
A single-blind, randomized, controlled study of a single, intra-articular injection of autologous microfractured adipose tissue (aMAT) in patients with osteoarthritis (OA) of the knee
Cartilage Repair Scaffold Seeding In Vitro Bosetti 2015
Human Lipoaspirate as Autologous Injectable Active Scaffold for One-Step Repair of Cartilage Defects
Randelli Rotator Cuff Biologic Study 2015 (002)
Lipogems Product Treatment Increases the Proliferation Rate of Human Tendon Stem Cells without Affecting Their Stemness and Differentiation Capability
Knee Injection Retrospective Results
Clinical experience with LIPOGEMS®: results of 1 year follow-up
Mesenchymal Stem Cells
Mesenchymal Stem Cells (MSC) Use In Hip Arthroscopy: Medium Term Results In Case-Control Study Of Patients With ICRS Grade 2-4 Defects?
Dr Morrison First Year Experience with Lipogems
First Year Experience with Lipogems
Allogeneic MSCs
Allogeneic MSCs and Recycled Autologous Chondrons Mixed in a One-Stage Cartilage Cell Transplantion: A First-in-Man Trial in 35 Patients
Arthroscopic Clinical Papers Lipogems treatment of chondral defects in the hip
AMIC, MACI, microfragmented adipose tissue transplantation (MATT) and other options
Arthroscopic Treatment of Chondral Lesions of the Hip
Arthroscopic treatment of chondral defects in the hip: AMIC, MACI, microfragmented adipose tissue transplantation (MATT) and other options
MSC use in Hip Arthroscopy
Mesenchymal Stem cells (MSC) use in hip arthroscopy: medium term results in case control study of patients with ICRS grade 2-4 defects
Allogeneic MSCs and Recycled Autologous Chondrons
Allogeneic MSCs and Recycled Autologous Chondrons Mixed in a One-Stage Cartilage Cell Transplantion: A First-in-Man Trial in 35 Patients
Mesenchymal Stem Cells and regenerative Medicine
Mesenchymal Stem Cells and regenerative Medicine. How Lipogems technology make them easy, safe and more effective to use. A short review
The Effect of Intra-articular Injection of Autologous Microfragmented Fat Tissue on Proteoglycan Synthesis in Patients with Knee Osteoarthritis
Abstract: Osteoarthritis (OA) is one of the leading musculoskeletal disorders in the adult
population. It is associated with cartilage damage triggered by the deterioration of the extracellular
matrix tissue.
Autologous and micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis
Background: Chondral lesions of the knee represent a challenge for the orthopaedic surgeon. Several treatments
have been proposed with variable success rate. Recently, new therapeutic approaches, such as the use of
mesenchymal stem cells, have shown promising results.

Adipose Tissue and Mesenchymal Stem Cells: State of the Art and Lipogems® Technology Development
Rizzoli protocol EN
A single-blind, randomized, controlled study of a single, intra-articular injection of autologous microfractured adipose tissue (aMAT) in patients with osteoarthritis (OA) of the knee
Cartilage Repair Scaffold Seeding In Vitro Bosetti 2015
Human Lipoaspirate as Autologous Injectable Active Scaffold for One-Step Repair of Cartilage Defects
Randelli Rotator Cuff Biologic Study 2015 (002)
Lipogems Product Treatment Increases the Proliferation Rate of Human Tendon Stem Cells without Affecting Their Stemness and Differentiation Capability
Knee Injection Retrospective Results
Clinical experience with LIPOGEMS®: results of 1 year follow-up
Mesenchymal Stem Cells
Mesenchymal Stem Cells (MSC) Use In Hip Arthroscopy: Medium Term Results In Case-Control Study Of Patients With ICRS Grade 2-4 Defects?
Dr Morrison First Year Experience with Lipogems
First Year Experience with Lipogems
Allogeneic MSCs
Allogeneic MSCs and Recycled Autologous Chondrons Mixed in a One-Stage Cartilage Cell Transplantion: A First-in-Man Trial in 35 Patients
Arthroscopic Clinical Papers Lipogems treatment of chondral defects in the hip
AMIC, MACI, microfragmented adipose tissue transplantation (MATT) and other options
Arthroscopic Treatment of Chondral Lesions of the Hip
Arthroscopic treatment of chondral defects in the hip: AMIC, MACI, microfragmented adipose tissue transplantation (MATT) and other options
MSC use in Hip Arthroscopy
Mesenchymal Stem cells (MSC) use in hip arthroscopy: medium term results in case control study of patients with ICRS grade 2-4 defects
Allogeneic MSCs and Recycled Autologous Chondrons
Allogeneic MSCs and Recycled Autologous Chondrons Mixed in a One-Stage Cartilage Cell Transplantion: A First-in-Man Trial in 35 Patients
Mesenchymal Stem Cells and regenerative Medicine
Mesenchymal Stem Cells and regenerative Medicine. How Lipogems technology make them easy, safe and more effective to use. A short review
The Effect of Intra-articular Injection of Autologous Microfragmented Fat Tissue on Proteoglycan Synthesis in Patients with Knee Osteoarthritis
Abstract: Osteoarthritis (OA) is one of the leading musculoskeletal disorders in the adult
population. It is associated with cartilage damage triggered by the deterioration of the extracellular
matrix tissue.
Autologous and micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis
Background: Chondral lesions of the knee represent a challenge for the orthopaedic surgeon. Several treatments
have been proposed with variable success rate. Recently, new therapeutic approaches, such as the use of
mesenchymal stem cells, have shown promising result.

 Patient Stories

Our Regenerative treatments can deliver simply life-changing results. Read our patient stories
to find out more

More than30,000 procedures performed
worldwide to date.

Fully CE Marked
& FDA Approved

 Patient Stories 

Our Regenerative treatments can deliver simply life-changing results. Read our patient stories
to find out more